Women’S Health In Rural American Communities,
2025
Touro College of Osteopathic Medicine
Women’S Health In Rural American Communities, Leandra Moukoudi Ndoko, Stephanie Zeszutek Do, Renee Reijo Pera Phd
Touro College of Osteopathic Medicine (Great Falls) Publications and Research
Limited data have been published on the status of women’s health in rural areas, particularly pertaining to women of color and rural women in the United States. The aim of this review is to briefly describe the trends in women’s health in rural areas, the factors contributing to poor health outcomes and potential ways to focus improvements most effectively. To provide this overview, approximately 310 articles were screened by full text on the database PubMed. Of these, 27 articles are described in more detail in this piece. Data focus on women’s health in the United States and include information bulletin …
A Look Into Postpartum T2dm Screening In Patients Diagnosed With Gdm,
2025
HCA Healthcare
A Look Into Postpartum T2dm Screening In Patients Diagnosed With Gdm, David Vincent Ream, Joshua Ferrell, Ashlee Nichole Tillery
South Atlantic Division GME Research Day 2025
No abstract provided.
Improving Knowledge And Confidence Of Family Nurse Practitioners In Offering The Hpv Vaccine,
2025
University of Texas at Arlington
Improving Knowledge And Confidence Of Family Nurse Practitioners In Offering The Hpv Vaccine, Leni Terano Fisher
Doctor of Nursing Practice (DNP) Scholarly Projects - Archive
Abstract
Introduction
Despite the recommendations of the United States Advisory Committee on Immunization Practices, HPV immunization lags behind other routine vaccines by up to 31%. Although there are many reasons for the low vaccine rate, provider hesitancy and lack of confidence significantly contribute to suboptimal HPV vaccine uptake.
Objectives
This project aimed to utilize evidence-driven interventions to increase family nurse practitioners' (FNPs) knowledge and confidence in offering the HPV vaccine.
Methods
Participants were given pre- and post-questionnaire surveys. The Wilcoxon Rank Test was used to compare, quantify, and measure the results of the eight-week data collection.
Results
The subjects were …
A Standardized Surgical Protocol For Placenta Accreta Spectrum Disorder At An Accreta Center Of Excellence,
2025
HCA Healthcare
A Standardized Surgical Protocol For Placenta Accreta Spectrum Disorder At An Accreta Center Of Excellence, Ana Adams, Monica Rodriguez, Kate Hansen, Aysu Erdemir, Robert Cohen
North Texas Research Forum 2025
Introduction Placenta Accreta Spectrum Disorder (PASD) refers to a spectrum of abnormal invasion of the placenta into the uterus during pregnancy. PASD ranges in severity from involvement through the endometrial layer of the uterus to complete invasion involving other pelvic structures. This abnormal invasion can result in significant postpartum hemorrhage, often requiring large-volume transfusions, about six units of packed red blood cells on average. The maternal mortality rate associated with PASD is approximately 4-7%. The Society for Maternal-Fetal Medicine (SMFM) recommends that pregnancies complicated by PASD be delivered in hospitals with dedicated interdisciplinary teams, referred to as “Accreta Centers of …
Marginal Cord Insertion And Funic Presentation Mimicking Vasa Previa,
2025
HCA Healthcare
Marginal Cord Insertion And Funic Presentation Mimicking Vasa Previa, Fran Franceschini Lopez, Andrew Tucker, Narinta Limtrakul, Manuel Rivera-Alsina
Central & West Texas and San Antonio GME Research Day 2025
No abstract provided.
Anca-Associated Pauci-Immune Glomerulonephritis Causing Aki In The Elderly: A Case Report,
2025
HCA Healthcare
Anca-Associated Pauci-Immune Glomerulonephritis Causing Aki In The Elderly: A Case Report, Jameel Osborne, Nimmy Joy, Nicolas Hernandez, Rodrigo Alfaro
Central & West Texas and San Antonio GME Research Day 2025
No abstract provided.
Five-Year Outcomes In Living Kidney Donors W. History Of Urolithiasis,
2025
HCA Healthcare
Five-Year Outcomes In Living Kidney Donors W. History Of Urolithiasis, Yara Alshawabkeh, Mohammad Abuassi, Geran Maule, Rabab Elsadek, Junaid Iqbal
North Florida Division GME Research Day 2025
No abstract provided.
Covid-19-Induced Activation Of Atypical Hemolytic Uremic Syndrome In A 40-Year-Old Woman With A Family History Of Ahus,
2025
HCA Healthcare
Covid-19-Induced Activation Of Atypical Hemolytic Uremic Syndrome In A 40-Year-Old Woman With A Family History Of Ahus, Neil Maithel, Ibrahim Musa, Rabia Mahfooz, Ali Asghar, Jorge Garza, Aftab Mahmood
Gulf Coast Division GME Research Day 2025
No abstract provided.
Implementation Of Screening For Vte Prophylaxis For The Prevention Of Vte In The Antepartum And Postpartum Period,
2025
HCA Healthcare
Implementation Of Screening For Vte Prophylaxis For The Prevention Of Vte In The Antepartum And Postpartum Period, Elizabeth Campos, Michelle Mieles, Aaron Poole
Central & West Texas and San Antonio GME Research Day 2025
No abstract provided.
Postpartum Glucose Testing And Primary Care Follow-Up For Women With Gestational Diabetes Mellitus: A Quality Improvement Project,
2025
HCA Healthcare
Postpartum Glucose Testing And Primary Care Follow-Up For Women With Gestational Diabetes Mellitus: A Quality Improvement Project, Madeline Bartram, Anusha Hussain, Timothy Kremer
North Texas Research Forum 2025
BACKGROUND: Patients with gestational diabetes mellitus (GDM) have a 40-70% lifetime risk for developing type 2 diabetes mellitus, which is 9 times the risk of patients without a history of GDM. Joint association guidelines recommend a 75-gram, 2-hour oral glucose tolerance test (GTT) at 4 to 12 weeks postpartum for all patients with GDM, and to follow-up with a primary care physician. Currently, less than half of these patients do not receive the recommended postpartum glucose testing and/or follow-up. METHODS: For each GDM-affected pregnancy, two primary outcome measures were retrospectively collected from the clinic EHR: completion of the 75-gram GTT …
Planned Out Of Hospital Birth Maternal And Neonatal Outcomes In A Single Institution,
2025
HCA Healthcare
Planned Out Of Hospital Birth Maternal And Neonatal Outcomes In A Single Institution, Priyanka Vuppala, Juhi Singhal, Linda Haddox
Central & West Texas and San Antonio GME Research Day 2025
No abstract provided.
Incarcerated Gravid Uterus,
2025
HCA Healthcare
Incarcerated Gravid Uterus, Adelene Morrow, Aaron Poole
Central & West Texas and San Antonio GME Research Day 2025
No abstract provided.
Management Of Placenta Accreta Spectrum Disorder Diagnosed Prior To Viability,
2025
HCA Healthcare
Management Of Placenta Accreta Spectrum Disorder Diagnosed Prior To Viability, Anjali Patel, Virginia Lowe, Linda Haddox
Central & West Texas and San Antonio GME Research Day 2025
No abstract provided.
Abnormal Pap Smears In Pregnancy And The Potential For Fulminant Cervical Cancer: A Case Report And Review Of Staging And Contemporary Treatment,
2025
HCA Healthcare
Abnormal Pap Smears In Pregnancy And The Potential For Fulminant Cervical Cancer: A Case Report And Review Of Staging And Contemporary Treatment, Aliya Nurani, Claud Crosby, Ashley Valenzuela, Meenah Dhir, Mikalah Maury, Stephen Salmieri, Anthony Royek
South Atlantic Division GME Research Day 2025
No abstract provided.
A Rare Case Of Vulvar Endometriosis,
2025
HCA Healthcare
A Rare Case Of Vulvar Endometriosis, Taylor Penny, Shelby Freeberg, Brittany Stofko
South Atlantic Division GME Research Day 2025
No abstract provided.
Diagnosis Of Hypertensive Disorders In Pregnancy,
2025
Macon & Joan Brock Virginia Health Sciences at Old Dominion University
Diagnosis Of Hypertensive Disorders In Pregnancy, Rebecca Horgan, Yara Hage Diab, Maged Costantine, George Saade, Baha Sibai
Department of Obstetrics & Gynecology Faculty Publications
Hypertensive disorders of pregnancy, including chronic hypertension, superimposed preeclampsia, gestational hypertension, and preeclampsia, affect 10-20% of pregnancies and are a significant cause of maternal and perinatal mortality. The incidence of these disorders is rising due to factors such as advanced maternal age, obesity, assisted reproductive technology, and increased rates of preexisting comorbidities. Differentiating pregnancy-associated hypertension from pre-existing chronic hypertension is challenging, as the overlap between the two may be broadening due to the changing demographics of the pregnant population. This review critically evaluated the evidence regarding the current time periods recommended to make a diagnosis of a hypertensive disorder of …
Reducing Unnecessary Antibiotics For The Treatment Of Urinary Tract Infections,
2025
West Chester University of Pennsylvania
Reducing Unnecessary Antibiotics For The Treatment Of Urinary Tract Infections, Megan A. Carullo
West Chester University Doctoral Projects
Urinary tract infections (UTIs) are among the most common infections in women and are often a reason for prescribing antibiotics. Appropriately treating these infections is vital to prevent significant health concerns such as pyelonephritis or sepsis. Providers commonly prescribe antibiotics as a preventive measure, but incorrect usage can lead to unnecessary use of antibiotics. This is a large concern for the medical community, given the increased rates of antibiotic resistance. This quality improvement project aimed to answer the following research question: In women with recurrent UTIs (rUTIs), does presumptive treatment compared to standard treatment upon confirmed infection increase the number …
A Case Of Recurrent Pleural Effusion Secondary To Thoracic Endometriosis Syndrome After Discontinuation Of Oral Contraceptives,
2025
HCA Healthcare
A Case Of Recurrent Pleural Effusion Secondary To Thoracic Endometriosis Syndrome After Discontinuation Of Oral Contraceptives, Kevin Gopala-Rao, Luis Santiesteban, Carmen Tormo Carrillo, Christian Almanzar Zorilla, Mauricio Danckers
East Florida Division GME Research Day 2025
Introduction: Thoracic endometriosis syndrome (TES) is a rare condition in which functional endometrial tissue spreads to the thoracic cavity. Manifestations of TES include catamenial hemoptysis, pneumothorax, and pleural effusions along with symptoms of dyspnea, cough, and pleuritic chest pain.1 Approximately 6 to 10% of women of reproductive-age women develop TES with concurrent pelvic endometriosis in 80% of patients.2 Treatment of TES includes medical management with progesterone-based oral contraceptive pills (OCPs) and surgical management involving cardiothoracic surgery. We present a case of recurrent pleural effusions in a patient who was non-compliant with medical management of TES. Methods: Data was collected during …
Optimization Of Venous Thromboembolism (Vte) Prophylaxis In Pregnancy And The Postpartum Period,
2025
HCA Healthcare
Optimization Of Venous Thromboembolism (Vte) Prophylaxis In Pregnancy And The Postpartum Period, Sereena Jivraj, Isabella Sciacca, Sherrie Dixon, Timothy Kremer
North Texas Research Forum 2025
Background: Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolisms (PE) continues to be a leading cause of maternal mortality (MM) in the United States. VTE accounts for roughly 9-10% of all maternal deaths. Other countries have adopted anticoagulation protocols to reduce MM rates, but the US has yet to follow suit. The American College of Obstetricians and Gynecologists (ACOG), the American College of Chest Physicians (CHEST), and the Royal College of Obstetricians and Gynaecologists (RCOG) all vary in their guidelines for thromboembolism prophylaxis. Patients who deliver by Cesarean section (C-section) have higher incidences of MM due …
Fibrillary Glomerulonephritis Associated With Hepatitis C: A Case Report Of Progression To End-Stage Renal Disease,
2025
HCA Healthcare
Fibrillary Glomerulonephritis Associated With Hepatitis C: A Case Report Of Progression To End-Stage Renal Disease, Boney Lapsiwala, Karthik Kasireddy, Marisha Sharma, Mayank Singh, Vaishnavi Singh, Victor Canela
North Texas Research Forum 2025
A Case of DNAJB9 with rapid renal progression to End-Stage Renal Disease in a patient with previously treated HCV Background Fibrillary glomerulonephritis (FGN) is a rare and progressive kidney disease, accounting for 0.5% to 1.4% of native kidney biopsies. It is characterized by non-amyloid fibrillar deposits in the extracellular matrix. Although historically regarded as idiopathic, recent studies have revealed associations with autoimmune diseases, malignancies, and Hepatitis C virus (HCV) infection. DNAJB9, a proteomic marker identified through mass spectrometry, has been consistently found in FGN cases, regardless of congophilia. This case illustrates FGN in a patient with a history of successfully …
